Anti-Kit x Anti-VCAM-1 Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-Kit and anti-VCAM-1 parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can retarget hematopoietic stem cells to injured myocardium. It is designed for the research of Cardiovascular disease therapy.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRY